HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lijie Xing Selected Research

Lijie Xing Research Topics

Disease

10Multiple Myeloma
12/2021 - 11/2017
5Neoplasms (Cancer)
12/2021 - 01/2020
2Bites and Stings (Sting)
12/2021 - 06/2020
1B-Cell Prolymphocytic Leukemia
01/2022
1Genomic Instability
01/2020
1Infections
03/2013

Drug/Important Bio-Agent (IBA)

5bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2021 - 01/2020
4Immunomodulating AgentsIBA
01/2021 - 01/2019
3Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2019
3daratumumabIBA
12/2021 - 11/2017
3Monoclonal AntibodiesIBA
12/2021 - 11/2017
3Immunoconjugates (Immunoconjugate)IBA
12/2021 - 01/2020
3Bortezomib (Velcade)FDA Link
10/2021 - 01/2020
2elotuzumabIBA
12/2021 - 11/2017
2Chimeric Antigen ReceptorsIBA
12/2021 - 06/2020
2AntigensIBA
12/2021 - 11/2020
2pomalidomideIBA
01/2020 - 01/2019
1zanubrutinibIBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1B-Cell Maturation AntigenIBA
12/2021
1LigandsIBA
10/2021
1Pharmaceutical PreparationsIBA
10/2021
1Proteins (Proteins, Gene)FDA Link
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1Messenger RNA (mRNA)IBA
01/2021
1Indicators and Reagents (Reagents)IBA
06/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2019
1Ligases (Synthetase)IBA
01/2019
1UbiquitinIBA
01/2019
1Complement System Proteins (Complement)IBA
11/2017
1Plant ExtractsIBA
03/2013
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
03/2013

Therapy/Procedure

4Immunotherapy
12/2021 - 11/2017
2Immunomodulation
12/2021 - 01/2020
2Therapeutics
10/2021 - 06/2020